Magle Chemoswed Holding AB (OSTO:MAGLE) EPS without NRI: kr-9.20 (TTM As of Mar. 2026)


OSTO:MAGLE Magle Chemoswed Holding AB OSTO:MAGLE
40 GF Score
Price kr1.01
GF Value kr22.57
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB EPS without NRI?

Magle Chemoswed Holding AB OSTO:MAGLE 40 EPS without NRI is kr-9.20 as of Mar. 2026. GuruFocus rates OSTO:MAGLE with a GF Score™ of 40/100 and a GF Value™ of kr22.57 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,168 Biotechnology companies, Magle Chemoswed Holding AB ranks worse than 85616.35% on this metric.

Magle Chemoswed Holding AB's earnings per share without non-recurring items for the three months ended in Mar. 2026 was kr-1.21. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr-9.20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Magle Chemoswed Holding AB's EPS without NRI or its related term are showing as below:

During the past 8 years, Magle Chemoswed Holding AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 140.10% per year. The lowest was -23.10% per year. And the median was 62.10% per year.

OSTO:MAGLE's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.4
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Magle Chemoswed Holding AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr-1.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-8.76.

Magle Chemoswed Holding AB's EPS (Basic) for the three months ended in Mar. 2026 was kr-1.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-8.76.


Magle Chemoswed Holding AB  (OSTO:MAGLE) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Magle Chemoswed Holding AB EPS without NRI Related Terms


Magle Chemoswed Holding AB EPS without NRI Historical Data

* Premium members only.

The historical data trend for Magle Chemoswed Holding AB's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magle Chemoswed Holding AB EPS without NRI Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial 0.40 1.01 1.02 0.18 -12.29

Magle Chemoswed Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -1.42 0.02 -6.58 -1.21

OSTO:MAGLE vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, Magle Chemoswed Holding AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's PE Ratio without NRI falls into.


OSTO:MAGLE
40GF Score
Magle Chemoswed Holding AB OSTO:MAGLE
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Magle Chemoswed Holding AB EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of kr-9.20 mean?
Magle Chemoswed Holding AB (OSTO:MAGLE) has a EPS without NRI of kr-9.20 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Magle Chemoswed Holding AB and its competitors. According to the industry distribution chart, Magle Chemoswed Holding AB ranks #999999 out of 1168 companies in the Biotechnology industry.
Is Magle Chemoswed Holding AB's EPS without NRI too high?
Magle Chemoswed Holding AB's current EPS without NRI is kr-9.20. Based on the distribution chart, Magle Chemoswed Holding AB ranks #999999 out of 1168 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Magle Chemoswed Holding AB has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Magle Chemoswed Holding AB's EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Magle Chemoswed Holding AB ranks #999999 out of 1168 companies for EPS without NRI. This places Magle Chemoswed Holding AB in the lower half of its industry. The industry median EPS without NRI is 16.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.40, based on 1,168 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Magle Chemoswed Holding AB and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Magle Chemoswed Holding AB's current EPS without NRI is kr-9.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magle Chemoswed Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Magle Chemoswed Holding AB (OSTO:MAGLE) is currently considered Possible Value Trap. The stock's GF Value™ is kr22.57, compared to a current price of kr1.01 — trading 95.5% below its estimated fair value. The current EPS without NRI is kr-9.20. Magle Chemoswed Holding AB's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Magle Chemoswed Holding AB (OSTO:MAGLE), the current EPS without NRI is kr-9.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Magle Chemoswed Holding AB (OSTO:MAGLE) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of kr1.01 is trading 95.5% below its estimated GF Value™ of kr22.57. GuruFocus considers Magle Chemoswed Holding AB to be Possible Value Trap.

Key valuation signals for OSTO:MAGLE:

  • EPS without NRI: kr-9.20
  • GF Value™: kr22.57 vs. price of kr1.01 (95.5% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the OSTO:MAGLE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Magle Chemoswed Holding AB Business Description

Other Exchanges 52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
40GF Score

Get the complete analysis for OSTO:MAGLE

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.01
Price
kr22.57
GF Value